Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Bone Marrow Transplant. 2010 May 17;46(2):285–290. doi: 10.1038/bmt.2010.113

TABLE 2.

Hospitalization and Infection Outcomes Among HSCT Recipients (N= 148)*

Variable Overall
(N=148)
Never
(N=81)
Previous
(N=45)
Current
(N=22)
P-value Adjusted P-value
Days hospitalized 30.0 ± 31.6 25.7 ± 25.3 29.8 ± 31.4 46.2 ± 46.3 0.025 0.009
Number of hospital admissions 2.4 ± 2.0 2.2 ± 1.9 2.5 ± 1.8 3.0 ± 2.8 0.19 0.062
Number of infections 1.9 ± 2.9 1.9 ± 3.0 1.8 ± 2.6 2.2 ± 3.2 0.86 0.86
*

Linear and multivariable-adjusted regression (age, disease status, transplant type) from the time of HSCT to 1 year post-HSCT. Hospital admissions and days hospitalized are not planned in the context of an outpatient-based program. Reported as mean ± standard deviation.